Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francine Foss

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
International Journal of Dermatology|October 20, 2017
Primary cutaneous aggressive epidermotropic cytotoxic CD8<sup>+</sup> T-cell lymphoma: long-term remission after brentuximab vedotinBenoit M Cyrenne, Antonio Subtil, Michael Girardi, et al.
Current Cancer Drug Targets|August 22, 2002
Diphtheria fusion protein therapy of chemoresistant malignanciesArthur E Frankel, Patrick Rossi, Timothy M Kuzel, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 2, 2023
Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case SeriesHaiming Tang, Nana Matsumoto, Francine Foss, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2016
Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis FungoidesFrancine Foss, Madeleine Duvic, Adam Lerner, et al.
Leukemia & Lymphoma|August 25, 2020
Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphomaKishan K Patel, Iris Isufi, Shalin Kothari, et al.
JID Innovations : Skin Science From Molecules to Population Health|September 7, 2023
FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical OutcomesJonathan Avery, Sa Rang Kim, Wei Cheng, et al.
BMJ Case Reports|October 2, 2019
<i>DUSP22-IRF4</i> rearrangement in AIDS-associated ALK-negative anaplastic large cell lymphomaMike Wang, Nour Kibbi, Nan Ring, et al.
Cytokine|November 21, 2002
Altered biological activity associated with C-terminal modifications of IL-7Güllü Görgün, Johanna van der Spek, Larry Cosenza, et al.
Blood Neoplasia|June 23, 2025
Pralatrexate injection combined with oral leucovorin for mucositis management in PTCL/CTCL treatment: a multicenter phase 2 trialSwaminathan P Iyer, Shaker Dakhil, Michi M Shinohara, et al.
British Journal of Haematology|June 4, 2014
Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell lymphomaJuliet Fraser Gibson, Francine Foss, Dennis Cooper, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
International Journal of Dermatology|October 20, 2017
Primary cutaneous aggressive epidermotropic cytotoxic CD8<sup>+</sup> T-cell lymphoma: long-term remission after brentuximab vedotinBenoit M Cyrenne, Antonio Subtil, Michael Girardi, et al.
Current Cancer Drug Targets|August 22, 2002
Diphtheria fusion protein therapy of chemoresistant malignanciesArthur E Frankel, Patrick Rossi, Timothy M Kuzel, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 2, 2023
Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case SeriesHaiming Tang, Nana Matsumoto, Francine Foss, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 18, 2016
Clinical Efficacy of Romidepsin in Tumor Stage and Folliculotropic Mycosis FungoidesFrancine Foss, Madeleine Duvic, Adam Lerner, et al.
Leukemia & Lymphoma|August 25, 2020
Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphomaKishan K Patel, Iris Isufi, Shalin Kothari, et al.
JID Innovations : Skin Science From Molecules to Population Health|September 7, 2023
FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical OutcomesJonathan Avery, Sa Rang Kim, Wei Cheng, et al.
BMJ Case Reports|October 2, 2019
<i>DUSP22-IRF4</i> rearrangement in AIDS-associated ALK-negative anaplastic large cell lymphomaMike Wang, Nour Kibbi, Nan Ring, et al.
Cytokine|November 21, 2002
Altered biological activity associated with C-terminal modifications of IL-7Güllü Görgün, Johanna van der Spek, Larry Cosenza, et al.
Blood Neoplasia|June 23, 2025
Pralatrexate injection combined with oral leucovorin for mucositis management in PTCL/CTCL treatment: a multicenter phase 2 trialSwaminathan P Iyer, Shaker Dakhil, Michi M Shinohara, et al.
British Journal of Haematology|June 4, 2014
Pilot study of sorafenib in relapsed or refractory peripheral and cutaneous T-cell lymphomaJuliet Fraser Gibson, Francine Foss, Dennis Cooper, et al.
Pageof 12